Patents by Inventor Lanny S. Liebeskind

Lanny S. Liebeskind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6221944
    Abstract: The product of reacting an organosilane optionally having a nonhydrolizable organic group, but having one ore more hydrolyzable groups, with a polyol containing at least three hydroxy groups, where any two of the hydroxy groups are separated by at least three intervening atoms. Water-stabilized organosilane compounds. A water stable composition made from the product or compound and water. A method of treating a substrate by contacting the substrate with the product, compound, or composition for a period of time sufficient for treatment of the substrate. A treated substrate having adhered thereto the product, compound, or composition.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: April 24, 2001
    Assignee: Emory University
    Inventors: Lanny S. Liebeskind, Gary D. Allred
  • Patent number: 5959014
    Abstract: The product of reacting an organosilane optionally having a nonhydrolizable organic group, but having one or more hydrolyzable groups, with a polyol containing at least three hydroxy groups, where any two of the hydroxy groups are separated by at least three intervening atoms. Water-stabilized organosilane compounds. A water stable composition made from the product or compound and water. A method of treating a substrate by contacting the substrate with the product, compound, or composition for a period of time sufficient for treatment of the substrate. A treated substrate having adhered thereto the product, compound, or composition.
    Type: Grant
    Filed: May 7, 1996
    Date of Patent: September 28, 1999
    Assignee: Emory University
    Inventors: Lanny S. Liebeskind, Gary D. Allred
  • Patent number: 4059593
    Abstract: Steganacin and Steganangin, dibenzocyclooctadiene lignan lactones, have been reported to possess anti-leukemic activity. This invention describes the first total synthesis of these compounds and other relevant intermediates.
    Type: Grant
    Filed: August 18, 1976
    Date of Patent: November 22, 1977
    Assignee: University of Rochester
    Inventors: Andrew S. Kende, Lanny S. Liebeskind
  • Patent number: 4003916
    Abstract: Steganacin and Steganangin, dibenzocyclooctadiene lignan lactones, have been reported to possess antileukemic activity. This invention describes the first total synthesis of these compounds and other relevant intermediates.
    Type: Grant
    Filed: December 22, 1975
    Date of Patent: January 18, 1977
    Inventors: Andrew S. Kende, Lanny S. Liebeskind